Background. Accurate prognostic models could inform treatment decisions for older adults with end-stage renal disease who are considering dialysis and might identify patients more appropriate for conservative care or hospice.
O LDER adults constitute a growing proportion of patients starting dialysis in the United States (1). The treated incidence rate of end-stage renal disease (ESRD) among patients aged 75 and older grew 12.2% between 2000 and 2012. In contrast to younger patients starting dialysis, older adults may not achieve a significantly prolonged life expectancy, particularly if they have ischemic heart disease, diabetes, or multiple comorbidities (2) . In fact, 1-year mortality after dialysis initiation in patients aged 80 and older is 46%, and 20%-30% of all deaths among older dialysis patients are preceded by dialysis withdrawal (3) . Consequently, there is uncertainty whether dialysis prolongs survival and/or improves health-related quality of life in older adults with multiple comorbidities compared with a conservative approach.
Many would argue that dialysis is also more burdensome in older patients. Establishing vascular access may be more complicated due to occlusive peripheral arterial disease or the loss of suitable veins for creation of arteriovenous fistulas or grafts (often related to prior cannulation during hospitalization). Approximately 80% of older adults in the United States initiate dialysis with central venous catheters (4) , which carry thromboembolic and infectious risks. The time, effort, and expense required in traveling to and from in-center hemodialysis is often magnified in older adults who often rely on medical transport systems or unpaid caregivers for transportation (5) . With these factors in mind, the risk/benefit ratio of dialysis weighs differently in older compared with younger patients.
Accurate prognostic models could inform treatment decisions and thereby facilitate provision of care congruent with patient's goals and values. There are no validated prognostic instruments for older adults starting dialysis in the United States that can be adapted to administrative data, therefore, we sought to compare the predictive accuracy of three existing risk stratification instruments. The Liu comorbidity index (6) was developed and validated in U.S. patients with ESRD using administrative data, but has not been validated in older adults. The French Renal Epidemiology and Information Network (REIN) index (7) was developed in patients aged 75 and older, but has not been tested in a U.S. population. We chose to evaluate the hospice eligibility criteria (HEC), an index based on the National Hospice and Palliative Care Organization guidelines for noncancer diagnoses (8) , because these criteria are used by clinicians to determine hospice eligibility for identifying patients with a prognosis of 6 months or less, although the criteria have not been tested in patients with ESRD. Our goal was to identify an existing index (or indices) that could most accurately predict short-term mortality among patients ≥67 years of age commencing dialysis using routinely available data collected in advance of dialysis initiation.
Methods

Data Source and Study Population
We used data from the United States Renal Data System, a national registry of patients with treated ESRD including virtually all persons who receive dialysis or kidney transplantation. In the Medicare ESRD program, nephrologists are required to submit to the Centers for Medicare and Medicaid Services a Medical Evidence Report, which includes information on sociodemographic characteristics, comorbidities, biometric data, and some ESRD-specific information. For patients aged 67 years or older, the United States Renal Data System also provides Medicare claims data covering at least 2 years of Medicare reimbursed health care encounters prior to start of treatment for ESRD (9) .
We assembled a cohort of all patients aged 67 or older with at least 2 years of Medicare fee-for-service (part A and B) coverage prior to the date of their dialysis initiation between January 1, 2008 and June 30, 2009. Patients with no valid Medicare claims in the 2 years before dialysis initiation were excluded (N = 443), resulting in a final cohort of 44,109.
Prognostic Indices
We adapted the three risk stratification indices using administrative data, as described in the Supplementary Table 1 . Comorbidities were considered to be present if the comorbidity was reported on the Medical Evidence Report or if they had at least one prior inpatient or two outpatient Medicare claims in the preceding 2 years. We used the same sets of diagnosis codes for comorbidities as those used by Liu and colleagues (6) , but changed the window of ascertainment to the 2 years preceding dialysis initiation. For comorbidities shared by the Liu and REIN scores, the aforementioned diagnosis codes were utilized, to maintain consistency. For the HEC, we evaluated only the five general clinical criteria in the current study since most patients in the current study would meet the disease-specific criteria for ESRD (ie, a glomerular filtration rate <10 or <15 mL/ min/1.73 m 2 with comorbid diabetes or heart failure). Several variables in the REIN score and HEC required additional adaptation (Supplementary Table 1 ). For example, in the REIN score, an unplanned dialysis start was operationalized as an inpatient dialysis start. Unintentional weight loss in the HEC was operationalized as Quetelet's body mass index <18.5 kg/m 2 or a prior claim for malnutrition. A recent decline in functional status in the HEC was adapted as the inability to ambulate or the inability to transfer.
Study Outcome
The primary outcome of interest was death from any cause within 6 months after dialysis initiation.
Statistical Analysis
We calculated a score for each patient using each of the three prognostic instruments. We applied weights for each variable as specified in the original reports. For example, congestive heart failure received a weight of 3 in the Liu index and a weight of 1 in the REIN index (6, 7) .
To better describe the cohort and evaluate the relative performance of scores across different age strata, we created three age categories: age 67 to <74, age 75 to <85, and ≥85 years. We used standard descriptive statistics to characterize the distribution of individual variables and each risk score in the analytic cohort, stratified by age group. Logistic regression was used to predict death at 6 months after dialysis initiation using each prognostic score (Liu, REIN, and HEC) as the independent variable. We repeated these procedures after inclusion of age in each model, to assess whether and how much model fit was improved by the addition of age. We also applied logistic regression stratified by age to assess model performance within age group. We compared models using the concordance ("c")-statistic, which corresponds to the area under the receiver operating characteristic curve. A c-statistic of 1.0 perfectly discriminates the outcomes, whereas a c-statistic of 0.5 is similar to a flip of a coin. The best model was selected by the higher c-statistic. We described the following test characteristics of each risk index across various cutoffs and the different age categories: sensitivity, specificity, positive and negative predictive values, positive and negative likelihoods. A likelihood ratio equal to one lacks prognostic value.
Missing Data
Approximately 27% of patients had at least one variable missing, ranging from 1% missing the ability to transfer to 24% missing serum albumin. Missing data did not affect the Liu score but affected the other two scores. As part of the modeling process, missing data were imputed by chain equations using the ICE command in Stata (StataCorp LP, College Station, TX) with five imputed data sets (10) . We used active imputation to impute the score directly but included the variables used to compute the score, the outcome, and age category in the imputation model if no missing data were present. Each imputed data set was analyzed separately and the results of the five fitted models were combined using the rules described by Little and Rubin (11) .
Analyses were performed using SAS software, version 9.2 (SAS Institute, Inc., Cary, NC) and StataMP, version 12 (StataCorp LP). This study was approved by an Institutional Review Board at Stanford University School of Medicine.
Results
Of the 44,109 patients in the analytic cohort, 54% were male, 78% were white, and 15% were ≥85 years of age ( Table 1 ). The overall burden of comorbidity was high. Most comorbid conditions were more common among older patients, with the exception of diabetes mellitus and liver disease. Older patients were more likely to have inpatient initiation of dialysis, multiple hospitalizations prior to dialysis, prior nursing home stay, inability to transfer or ambulate, lower body mass index, or a diagnosis of malnutrition. The distribution of scores from each risk index is shown in Figure 1 . The median risk scores were 10 (range 0-21), 6 (range 0-16), and 1 (range 0-5) for the Liu, REIN, and HEC indices, respectively.
Twenty-three percentage of the cohort died within 6 months of starting dialysis. For each prediction index, patients with higher scores were more likely to die within 6 months than those with a lower score. The combined Liu index and HEC had better discrimination than any of the single scores. However, none of the models were sensitive nor did they substantially vary in their predictive capacity (Figure 2) . Specifically, the c-statistic for the Liu, REIN, HEC, and combined Liu/HEC scores were 0.62, 0.63, 0.65, and 0.67, respectively. When age was added to the models, the c-statistics for the Liu, REIN, HEC, and combined Liu/ HEC scores were 0.65, 0.66, 0.68, and 0.70, respectively (Table 2) .
Notably, the discrimination of these indices was worse with older age (Table 3 ). For example, the Liu score had c-statistics of 0.64, 0.62, and 0.56 among those aged 67-74, 75-84, and ≥85 years, respectively. A similar decrement in the c-statistic was noted at older ages with the REIN score; Notes: BMI = body mass index. *Missing data include: race (n = 14), inability to transfer (n = 552; due to missing medical evidence form), unable to ambulate or transfer (n = 552), albumin (n = 10,686). p Values were computed using Cochran-Armitage trend test.
however with the HEC, the c-statistic was similar at across all age groups.
The Liu index demonstrated a loss of sensitivity and gain of specificity with older age. For example, a Liu score ≥10 had a sensitivity of 92% for age 67 to <75 but only 66% in the ≥85-year-old category, whereas specificity increased from 9% to 49%, in the same categories. In contrast, the REIN, HEC, and combined Liu and HEC indices showed a loss of specificity with older age, but sensitivity remained constant. Although none of the indices had high sensitivity and specificity, several had cutpoints with high sensitivity or specificity. For example, a REIN score ≥9 and a HEC score ≥3 have specificities between 80%-92% and 90%-93%, respectively, across the three age categories. Combining the Liu and HEC resulted in poorer sensitivity and only incrementally better specificity (for age ≥85 years, specificity was incrementally worse).
Discussion
We adapted the Liu index, REIN index, and HEC to administrative data and evaluated the predictive capacity of these indices in identifying older adults at high risk of early mortality after starting dialysis. Our study demonstrates that older patients initiating dialysis in the United States carry a high burden of comorbidity and impaired functional capacity, and that the percentage of patients surviving 6 months on dialysis decreases with more extensive comorbidity, lower functional status, and older age. However, none of the three risk indices discriminated very well.
Surprisingly, few prior studies have evaluated prognostic indices specifically in older adults commencing dialysis. A risk score devised from an Australian cohort of patients aged 75 and older incorporated practice characteristics, such as unprepared access, dialysis modality at start compared with intended modality, and late referral along with comorbid conditions, but the score failed to meet its prespecified threshold for discrimination (c-statistic of 0.7) (12).
The "surprise" question ("would you be surprised if this patient died within the next year?") predicts death within 12 months for general ESRD populations as well as non-ESRD populations (13) (14) (15) . The elements of the surprise question that are appealing include the simplicity and ease with which it is administered. It may capture intangible aspects of the clinical impression including comorbidity, functional status, frailty, and social support to synthesize a holistic assessment of the patient. These aspects make it impossible to capture from administrative data, as it is innately subjective and as a result, may lack external validity. The surprise question was combined with age, presence of peripheral vascular disease or dementia, and serum albumin to create a validated prognostic index with a c-statistic of 0.80 (16) . However, it was derived from prevalent hemodialysis patients of all ages and has not been validated in the older adults. Other individual variables included in this prognostic index, age, dementia, peripheral vascular disease, and serum albumin, had lower magnitude though generally similar associations with 6-month mortality in our cohort (data not shown). This suggests that lower discrimination of the prognostic indices we studied compared with the Cohen prognostic index was primarily due to the intangibles captured by the surprise question rather than differences in the study population or variable definitions.
This study indicates that two published prognostic indices primarily based on comorbidity (Liu and REIN) (6,7) fail to discriminate among older patients who live or die within 6 months of commencing dialysis. For example, among patients ≥85 years the c-statistic was 0.56 and 0.59 for the Liu and REIN indices. The HEC, which is based on functional capacity, yielded superior prognostic performance, with a c-statistic of 0.65 in those ≥85 years that was stable across age categories studied. This demonstrates that the sum of comorbid conditions fails to predict mortality in older adults and suggests that functional measures may also be relevant in prognostication.
There are a few possible explanations as to why these indices perform poorly. First, the tools omitted, or only crudely captured functional status and geriatric syndromes such as frailty, depression, and cognitive impairment, which are likely to be important predictors of mortality in older patients (17) . Second, adaptation of two of the tools (REIN, HEC) to administrative data may have lessened their predictive accuracy. For example, the original REIN index assigns one point to patients with class 3 or 4 congestive heart failure, whereas in the current study all patients with a diagnosis code of congestive heart failure were assigned a point. Conversely, administrative claims are known to be insensitive to certain diagnoses, such as dementia. Third, variability in disease trajectory may arise from acute illnesses (18) . Related to this point, indices which focus on a single point in time are likely to miss critical information that might be obtained by observing a trend. Temporal changes in nutritional and functional status are captured in the HEC, but were difficult to ascertain using administrative data.
The decision-making process surrounding renal replacement therapy is complex for clinicians as well as for the patient and the family. Patients have poor knowledge of both dialysis and the lifestyle changes inherent with it as well as nondialysis alternatives and data show that many regret the decision to initiate dialysis (19, 20) or feel they have no choice in the decision (5) . An accurate prediction of mortality risk specific to older adults could be useful for engaging patients in the decision-making process. Although this would not guarantee shared decision making, it might allow for better informed decisions. Janssen and colleagues (21) showed that hemodialysis patients can make decisions regarding advanced care planning based on expected outcomes. Wachterman and colleagues (22) reported that very few patients with ESRD receive prognostic estimates from their nephrologists. One reason may be a lack of confidence in prognostication and the fear that they may be proven wrong. Rather than avoiding end of life discussions, clinicians should leverage this prognostic uncertainty to conduct open-ended conversations and explore patient values and goals as well as end of life preferences and help patients create and implement preference-sensitive care.
In practice, a risk prediction tool with low sensitivity and high specificity could still be useful in decision making around dialysis versus conservative care and possible referral to hospice. For example, a REIN score with a cutpoint of 9 or an HEC with a cutpoint of 3, will miss patients with high mortality (false negatives), but will rarely misclassify persons likely to survive as having a high risk of dying (few false positives), since high specificity would prevent erroneous underestimation of a given patient's early mortality risk.
There are several limitations to our study. First, the United States Renal Data System does not contain information about patients with ESRD who do not initiate dialysis. It is possible the risk scores we studied may have performed differently if all patients with ESRD could be included in the analytic cohort. Second, although our findings are generalizable to U.S. patients, they may not be generalizable to patients on dialysis in other countries.
Older adults commencing dialysis are a growing population with a high average mortality rate. Our study shows that existing indices to predict 6-month mortality exhibit relatively poor discrimination. Future studies are necessary to determine whether the addition of geriatric measures such as frailty will help to identify patients with a poor short-term prognosis. These findings also underscore the importance of an informed, shared decision-making process that takes into account patient values and preferences, in addition to predicted prognosis, when approaching decisions to start or stop dialysis.
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